(18928389), M. C. J., (22676472), G. A. R., (6887384), J. M. S., (783181), N. C., (22676475), M. C. T., & (22676478), L. M. N. (2025). Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial: Aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
Chicagoスタイル(17版)引用形式(18928389), Maria C. Jugan, Gabrielle A. Rands (22676472), Joerg M. Steiner (6887384), Natalia Cernicchiaro (783181), Matthew C. Tanner (22676475), , Lillian M. Novotny (22676478). Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.
MLA(9版)引用形式(18928389), Maria C. Jugan, et al. Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.